chr2-98391964-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_001298.3(CNGA3):āc.667C>Gā(p.Arg223Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R223Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001298.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGA3 | NM_001298.3 | c.667C>G | p.Arg223Gly | missense_variant | 7/8 | ENST00000272602.7 | NP_001289.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGA3 | ENST00000272602.7 | c.667C>G | p.Arg223Gly | missense_variant | 7/8 | 1 | NM_001298.3 | ENSP00000272602.2 | ||
CNGA3 | ENST00000436404.6 | c.613C>G | p.Arg205Gly | missense_variant | 6/7 | 1 | ENSP00000410070.2 | |||
CNGA3 | ENST00000409937.1 | n.820C>G | non_coding_transcript_exon_variant | 7/8 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251150Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135756
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461402Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 727028
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2021 | The c.667C>G (p.R223G) alteration is located in exon 7 (coding exon 6) of the CNGA3 gene. This alteration results from a C to G substitution at nucleotide position 667, causing the arginine (R) at amino acid position 223 to be replaced by a glycine (G). Based on data from gnomAD, the G allele has an overall frequency of <0.01% (9/251150) total alleles studied. The highest observed frequency was 0.09% (9/10080) of Ashkenazi Jewish alleles. This alteration has been reported in a patient with achromatopsia in combination with a second CNGA3 alteration (Wiszniewski, 2007). Two alterations affecting the same amino acid, p.R223W and p.R223Q, have also been reported in association with achromatopsia (Wissinger, 2001; Fahim, 2013; Greenberg, 2014; Li, 2014). This amino acid position is not well conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic. - |
Achromatopsia Pathogenic:1
Pathogenic, no assertion criteria provided | research | Sharon lab, Hadassah-Hebrew University Medical Center | Jun 23, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at